A detailed history of Spider Rock Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 8,906 shares of BSX stock, worth $807,417. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,906
Previous 10,304 13.57%
Holding current value
$807,417
Previous $793,000 5.93%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$72.96 - $84.0 $101,998 - $117,432
-1,398 Reduced 13.57%
8,906 $746,000
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $693,768 - $800,723
10,304 New
10,304 $793,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Spider Rock Advisors, LLC Portfolio

Follow Spider Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.